Season 2

How the Indestructible Molecule that is PFAS Effects the Environment

In the most recent episode of “There’s More to IT,” host Jason Claybrook discussed the widespread exposure of Per and Polyfluoroalkyl Substances, better known as PFAS, in various aspects of everyday life. His guest was Yuran Li, the director of MS Commercial Strategies at Alternative Biomedical Solutions — a Texas based laboratory. The two talked…

Read More

Latest

Season 2
Mastering the Science Behind Creating an IT Department

In this episode of There’s More to IT, host, Jason Claybrook, sat down with David McLaughlin, President & CEO, Columbia Advisory Group. The two discuss McLaughlin’s journey in the field, the importance of the advisory component in CAG’s work, and CAG’s role in higher education. McLaughlin co-founded Columbia Advisory Group a little over 10…

Read More
Food & Beverage
Is Holistic Nutrition the Answer for Improving Overall Nutritional Needs?

In the latest episode of the podcast “There’s More to IT,” host Jason Claybrook brings on his wife Niki, and diverges from technology to discuss maintaining healthy-eating habits, as more and more people return to work traveling as pandemic restrictions ease. As a holistic nutrition consultant based in Texas, Claybrook consults clients that have…

Read More
Season 2
Technology Leaders Are No Longer Behind the Scenes, They Are Integral for Driving Strategy

Toby Buckalew, Interim CIO, Columbia Advisory Group, is a leading technology strategist with over thirty years of industry experience. Jason Claybrook sat down with Buckalew for an in-depth discussion on his career and insights into the current state of IT management. Buckalew witnessed plenty of technology evolution and innovation during his lengthy career in…

Read More
Sciences
The Industry That is Depending on Science and Regulation to Grow

Yuran Li, Director, MS Commercial Strategies, Alternative Biomedical Solutions (ABS), is a biochemist by training. Still, his fascinations with physics, math, and probability have led him down some interesting paths, including some stints in the professional poker world. Lucky for ABS, he chose the science route. Cannabis is a schedule 1 drug classification by the…

Read More

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More